Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium.

Am J Clin Nutr

From the Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA (DM); the Divisions of Cardiovascular Medicine (DM and PMR), Genetics (DIC), Preventive Medicine (LW, DIC, AYC, and PMR), and Aging (LD) and the Channing Division of Network Medicine (DM, QS, EBR, FBH), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; the Departments of Epidemiology (DM, EBR, and FBH) and Nutrition (DM, QS, H Wu, MKJ, EBR, and FBH), Harvard School of Public Health, Boston, MA; the Department of Medicine (COJ, RNL, BMP, and DSS), School of Medicine, and the Departments of Biostatistics (BM), Epidemiology (DSS and BMP), and Health Services (BMP), School of Public Health, University of Washington, Seattle, WA; the Group Health Collaborative Research Institute, Seattle, WA (BMP); Center for Public Health Genomics (AM and SSR) and the Division of Biostatistics (AM), Department of Public Health Sciences, University of Virginia, Charlottesville, VA; the Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (EKK); the Division of Epidemiology & Community Health, School of Public Health (LS) and Department of Laboratory Medicine & Pathology (MYT), University of Minnesota, Minneapolis, MN; Institute of Molecular Medicine (M Foy and M Fornage) and Division of Epidemiology (M Fornage), Human Genetics, and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX; Division of Genomic Outcomes, Department of Pediatrics, Harbor-UCLA Medical Center, Los Angeles, CA (IY-DC); The George Institute for Global Health, University of Sydney, Australia (JHYW); and the Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL (H Wiener, MRI, and DKA).

Published: February 2015

Background: Circulating trans fatty acids (TFAs), which cannot be synthesized by humans, are linked to adverse health outcomes. Although TFAs are obtained from diet, little is known about subsequent influences (e.g., relating to incorporation, metabolism, or intercompetition with other fatty acids) that could alter circulating concentrations and possibly modulate or mediate impacts on health.

Objective: The objective was to elucidate novel biologic pathways that may influence circulating TFAs by evaluating associations between common genetic variation and TFA biomarkers.

Design: We performed meta-analyses using 7 cohorts of European-ancestry participants (n = 8013) having measured genome-wide variation in single-nucleotide polymorphisms (SNPs) and circulating TFA biomarkers (erythrocyte or plasma phospholipids), including trans-16:1n-7, total trans-18:1, trans/cis-18:2, cis/trans-18:2, and trans/trans-18:2. We further evaluated SNPs with genome-wide significant associations among African Americans (n = 1082), Chinese Americans (n = 669), and Hispanic Americans (n = 657) from 2 of these cohorts.

Results: Among European-ancestry participants, 31 SNPs in or near the fatty acid desaturase (FADS) 1 and 2 cluster were associated with cis/trans-18:2; a top hit was rs174548 (β = 0.0035, P = 4.90 × 10(-15)), an SNP previously associated with circulating n-3 and n-6 polyunsaturated fatty acid concentrations. No significant association was identified for other TFAs. rs174548 in FADS1/2 was also associated with cis/trans-18:2 in Hispanic Americans (β = 0.0053, P = 1.05 × 10(-6)) and Chinese Americans (β = 0.0028, P = 0.002) but not African Americans (β = 0.0009, P = 0.34); however, in African Americans, fine mapping identified a top hit in FADS2 associated with cis/trans-18:2 (rs174579: β = 0.0118, P = 4.05 × 10(-5)). The association between rs174548 and cis/trans-18:2 remained significant after further adjustment for individual circulating n-3 and n-6 fatty acids, except arachidonic acid. After adjustment for arachidonic acid concentrations, the association between rs174548 and cis/trans-18:2 was nearly eliminated in European-ancestry participants (β-coefficient reduced by 86%), with similar reductions in Hispanic Americans and Chinese Americans.

Conclusions: Our findings provide novel evidence for genetic regulation of cis/trans-18:2 by the FADS1/2 cluster and suggest that this regulation may be influenced/mediated by concentrations of arachidonic acid, an n-6 polyunsaturated fat.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307209PMC
http://dx.doi.org/10.3945/ajcn.114.094557DOI Listing

Publication Analysis

Top Keywords

fatty acids
16
european-ancestry participants
12
african americans
12
hispanic americans
12
associated cis/trans-182
12
arachidonic acid
12
associated circulating
8
trans fatty
8
americans
8
chinese americans
8

Similar Publications

Metabolic profiling reveals altered amino acid and fatty acid metabolism in children with Williams Syndrome.

Sci Rep

December 2024

Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, National Children's Regional Medical Center, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou, 310052, Zhejiang Province, China.

Williams Syndrome (WS) is a rare neurodevelopmental disorder with a prevalence of 1 in 7500 to 1 in 20,000 individuals, caused by a microdeletion in chromosome 7q11.23. Despite its distinctive clinical features, the underlying metabolic alterations remain largely unexplored.

View Article and Find Full Text PDF

Limited knowledge exists regarding biomarkers that predict treatment response in Lupus nephritis (LN). We aimed to identify potential molecular biomarkers to predict treatment response in patients with LN. We enrolled 66 patients with active LN who underwent renal biopsy upon enrollment.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is a severe neurodegenerative disease, and the most common type of dementia, with symptoms of progressive cognitive dysfunction and behavioral impairment. Studying the pathogenesis of AD and exploring new targets for the prevention and treatment of AD is a very worthwhile challenge. Accumulating evidence has highlighted the effects of fatty acid metabolism on AD.

View Article and Find Full Text PDF

Resolvin D1 (RvD1) is an endogenous anti-inflammatory mediator that modulates the inflammatory response and promotes inflammation resolution. RvD1 has demonstrated neuroprotective effects in various central nervous system contexts; however, its role in the pathophysiological processes of intracerebral hemorrhage (ICH) and the potential protective mechanisms when combined with exercise rehabilitation remain unclear. A mouse model of ICH was established using collagenase, and treatment with RvD1 combined with three weeks of exercise rehabilitation significantly improved neurological deficits, muscle strength, learning, and memory in ICH mice while reducing anxiety-like behavior.

View Article and Find Full Text PDF

Small intestinal organoids are similar to actual small intestines in structure and function and can be used in various fields, such as nutrition, disease, and toxicity research. However, the basal-out type is difficult to homogenize because of the diversity of cell sizes and types, and the Matrigel-based culture conditions. Contrastingly, the apical-out form of small intestinal organoids is relatively uniform and easy to manipulate without Matrigel.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!